Cancer Research News | ScienceMyHealth

Could GLP-1 Drugs Play a Role in Breast Cancer Prevention?

Jun 11, 2026

What if a GLP-1 medicine known for weight loss and type 2 diabetes was also linked to lower breast cancer rates? That is the question behind a new study on GLP-1 medicines.
Researchers looked at health records from women who had breast imaging and found that those exposed to GLP-1 medicines had a lower rate of breast cancer than those who were not. This does not prove that GLP-1 medicines prevent breast cancer. It shows an association. But it is a strong enough signal that researchers say it deserves more study.

Could GLP-1 Medicines Help Lower Breast Cancer Risk?

Jun 9, 2026

GLP-1 medicines are best known for treating type 2 diabetes and helping with weight loss. Now, researchers are studying whether these medications may have other health effects, including a possible link to lower breast cancer risk. A new study looked at women who had breast imaging and found that those prescribed GLP-1 medicines had a lower rate of breast cancer...

Colorectal Cancer Screening Just Changed

Jun 8, 2026

Here’s What You Need to Know to Prevent Cancer!
Colorectal cancer is one of the most preventable cancers. And yet, it’s still one of the most common.
That disconnect is exactly why the American Cancer Society updated its colorectal cancer screening guidelines in 2026. Not because screening doesn’t work — but because not enough people are doing it.

Updated 2026 Colorectal Cancer Screening Guidelines: What’s New and Why It Matters

Jun 6, 2026

Colorectal cancer remains one of the most common and preventable cancers, yet many adults miss recommended screenings. In May 2026, the American Cancer Society (ACS) released an updated set of colorectal cancer screening guidelines aimed at increasing early detection and saving more lives. These changes reflect new research and advances in technology that make...

Can Anti-Inflammatory Drugs Prevent Lung Cancer? What New Research Reveals

Jun 3, 2026

Lung cancer remains the leading cause of cancer death worldwide. For decades, we believed it was mainly caused by smoking and genetic mutations. While mutations are still important, new research shows they are only part of the story. Inflammation may be the missing link.Scientists are now studying whether anti-inflammatory drugs could help treat — and even prevent — lung cancer. The idea is simple but powerful: if inflammation helps cancer grow, stopping inflammation may stop cancer too.

Low-Dose Endoxifen: Is it Possible to Lower Breast Cancer Risk by Reducing Breast Density?

May 23, 2026

A new clinical trial suggests that a low daily dose of endoxifen may help lower breast cancer risk by reducing breast density. Breast density is an important risk factor for breast cancer and can also make tumors harder to detect on mammograms. In this study, researchers found that even small doses of endoxifen led to meaningful reductions in breast density with manageable side effects.

Cancer